IP Library Granted Patent US 8,110,378
Granted Patent B2
US 8,110,378 · App. 13/149,643 · Granted Feb 7, 2012

Nucleic acids encoding DCRS5

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,110,378
App. No.
13/149,643
Granted
Feb 7, 2012
Kind
B2
Abstract

Nucleic acids encoding mammalian, e.g., primate, receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.

Claims (24)

1. An isolated or recombinant polynucleotide encoding a recombinant polypeptide comprising a sequence having at least 95% sequence identity with residues 1-606 of SEQ ID NO:2, wherein the polypeptide, when combined with IL-12Rβ1, is able to form a functional receptor complex for p40/IL-B30.

2. A method of producing a polypeptide comprising a sequence having at least 95% sequence identity with residues 1-606 of SEQ ID NO:2 comprising:

a) culturing an isolated host cell comprising an expression vector comprising the polynucleotide of claim 1 under conditions suitable for expression of the polypeptide; and

b) isolating or purifying the polypeptide.

3. The polynucleotide of claim 1 , wherein the polypeptide has at least 98% sequence identity with residues 1-606 of SEQ ID NO:2.

4. A method of producing a polypeptide comprising a sequence having at least 98% sequence identity with residues 1-606 of SEQ ID NO:2 comprising:

a) culturing an isolated host cell comprising an expression vector comprising the polynucleotide of claim 3 under conditions suitable for expression of the polypeptide; and

b) isolating or purifying the polypeptide.

5. The polynucleotide of claim 3 , wherein the polypeptide has fewer than 5 substitutions relative to residues 1-606 of SEQ ID NO:2.

6. A method of producing a polypeptide comprising a sequence having fewer than 5 substitutions relative to residues 1-606 of SEQ ID NO:2 comprising:

a) culturing an isolated host cell comprising an expression vector comprising the polynucleotide of claim 5 under conditions suitable for expression of the polypeptide; and

b) isolating or purifying the polypeptide.

7. An isolated polynucleotide encoding a recombinant polypeptide comprising a sequence having at least 95% sequence identity with the polypeptide of SEQ ID NO:2, wherein the polypeptide, when combined with IL-12Rβ1, is able to form a functional receptor complex for p40/IL-B30.

8. A method of producing a polypeptide comprising a sequence having at least 95% sequence identity with the polypeptide of SEQ ID NO:2 comprising:

a) culturing an isolated host cell comprising an expression vector comprising the polynucleotide of claim 7 under conditions suitable for expression of the polypeptide; and

b) isolating or purifying the polypeptide.

9. The polynucleotide of claim 7 , wherein the polypeptide has at least 98% sequence identity with the polypeptide of SEQ ID NO:2.

10. A method of producing a polypeptide comprising a sequence having at least 98% sequence identity with the polypeptide of SEQ ID NO:2 comprising:

a) culturing an isolated host cell comprising an expression vector comprising the polynucleotide of claim 9 under conditions suitable for expression of the polypeptide; and

b) isolating or purifying the polypeptide.

11. The polynucleotide of claim 9 , wherein the polypeptide has fewer than 5 substitutions relative to the polypeptide of SEQ ID NO:2.

12. A method of producing a polypeptide comprising a sequence having fewer than 5 substitutions relative to the polypeptide of SEQ ID NO:2 comprising:

a) culturing an isolated host cell comprising an expression vector comprising the polynucleotide of claim 11 under conditions suitable for expression of the polypeptide; and

b) isolating or purifying the polypeptide.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →